• Transactions
  • Careers
  • Contact
  • Client Login
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

SVB Securities

Helping our clients move healthcare and technology forward

  • Sectors
    • Healthcare
      • Biopharma
      • Digital Health & HealthTech
      • Healthcare Services
      • Medical Technology
      • Tools & Diagnostics
    • Technology
      • Consumer Internet, Commerce Enablement & Marketing Software
      • Digital Infrastructure & Tech-Enabled Services
      • Learning Technology
      • Enterprise Software
      • Industrial Technology
      • Fintech
  • Solutions
    • For Corporates
      • M&A Advisory
      • Capital Markets
      • Leveraged Finance & Structured Finance
    • For Investors
      • Equity Research
      • Institutional Equities
      • Corporate Access
  • Intelligence
    • Perspectives
    • SVB MEDACorp
  • Firm
    • About
    • Careers
    • News
    • Transactions

Redefining Investment Banking

An investment bank uniquely dedicated to serving innovation-driven healthcare and technology companies

Contact Us

Why Partner With Us

At SVB Securities, we share a singular goal to achieve the highest level of success for our clients. We pride ourselves on being the most focused and passionate investment banking professionals in the business.

Learn more

1,150+

Transactions Completed

since 2009Learn More

$225+

Billion
Raised

since 2009Learn More

~355+

Companies
Covered

as of 12/31/2022Learn More

20K+

Key Opinion Leaders in Healthcare

as of 12/31/2020Learn More

Our Expertise

We provide healthcare and technology-focused companies and investors a broad suite of financial solutions comprising of M&A advisory, equity and debt capital markets, proprietary research, and comprehensive sales and trading capabilities.

Capital Markets

We are a market leader partnering with innovative healthcare and technology companies throughout their financial lifecycle. Learn More

M&A Advisory

We leverage our long-term relationships, highly-regarded sector knowledge and transaction experience to deliver outcomes for our clients. Learn More

Institutional Equities

Delivering unique insights on equity-related products for institutional clients. Learn More

Equity Research

Industry recognized equity research analysts offer a differentiated perspective on the healthcare and technology sub-sectors driving innovation. Learn More

Leveraged/Structured Finance

Corporate clients and financial sponsors require expertise in structuring, underwriting, and syndicating a broad array of debt financing solutions. Learn more

SVB MEDACorp

Exclusive access to Key Opinion Leaders (KOLs) and healthcare professionals is an essential service for our Equity Research and Investment Banking teams and healthcare clients as they evaluate opportunities. Learn More

Recent Transactions

See all transactions

$117 Million

Joint Bookrunner
Follow-On
January 2023

$125 Million

Joint Bookrunner
Follow-On
January 2023

UNDISCLOSED

Exclusive Financial Advisor
Strategic Investment from InTandem Capital Partners
January 2023

Up to CHF 200 MILLION

Exclusive Financial Advisor
Sale to Tandem Diabetes Care, Inc.
Pending

$500 MILLION

Joint Bookrunner
Rule 144A Convertible Senior Notes
December 2022

UNDISCLOSED

Exclusive Financial Advisor
Sale to Intuit
Pending

$60 MILLION

Joint Bookrunner
Follow-On
November 2022

$260 Million + Up to $1.8B in Milestone Payments

Exclusive Financial Advisor
Exclusive Licensing Agreements with Point Biopharma
Pending

$50 MILLION

Joint Bookrunner
Follow-On
November 2022

$575 MILLION

Joint Bookrunner
Follow-On
November 2022

$80 MILLION

Joint Bookrunner
Follow-On
November 2022

$500 MILLION

Joint Bookrunner
Follow-On
December 2022

Recent News

View All
SVB Securities Serves as Joint Bookrunner for Olink’s (Nasdaq: OLK) $117 Million Follow-On Offering
Learn More
SVB Securities Serves as Joint Bookrunner for Fulcrum Therapeutics’ (Nasdaq: FULC) $125 Million Follow-On Offering
Learn More
SVB Securities Serves as Exclusive Financial Advisor to AMF Medical SA on its Sale to Tandem Diabetes Care, Inc. (Nasdaq: TNDM)
Learn More
SVB Securities Serves as Joint Bookrunner for Replimune’s (Nasdaq: REPL) $225 Million Follow-On Offering
Learn More
SVB Securities Serves as Joint Bookrunner for Prometheus Biosciences’ (Nasdaq: RXDX) $500 Million Follow-On Offering
Learn More
SVB Securities Serves as Joint Bookrunner to Lantheus (NASDAQ: LNTH) on its $500 Million Rule 144A Offering of Convertible Senior Notes
Learn More
SVB Securities Serves as Lead-Left Bookrunner for Aura Biosciences’ (Nasdaq: AURA) $80 Million Follow- On Offering
Learn More
SVB Securities Served as PIPE Placement Agent to Frazier Lifesciences Acquisition Corp. (Nasdaq: FLAC) and Financial Advisor and Capital Markets Advisor to NewAmsterdam Pharma in Connection with its Completed Merger and $235 Million PIPE
Learn More

Featured Intelligence

View additional intelligence
Articles

Digital Health’s Dot Com Moment – Peril and Promise

September 2022
Featured Research

Biopharma / SITC 2022: IO Development and Regulatory Discussions

December 2022
Featured Research

Healthcare Technology & Distribution / 2022 Digital Health: Innovators & Disruptors Conference Takeaways

November 2022

Partner with Us

to achieve your strategic, capital markets, and investment objectives.

Contact Us

Footer

Sectors

  • Healthcare
  • Technology

Solutions

  • For Corporates
  • For Investors
  • Transactions
  • Advisory

Intelligence

  • Perspectives
  • Research
  • SVB MedaCorp

Firm

  • About
  • Careers
  • News

Contact

  • General
  • Investors
  • Press
  • SVB.com

Stay ahead of what’s next. Sign Up Now!

Subscribe to receive our thought leadership and marketing updates.

Member  FINRA/SIPC

  • Terms of Use
  • Privacy
  • Cookies
  • Corporate Governance
  • Notice to California Residents
  • Important Disclosures
  • Linkedin
  • Mail
An SVB Company

Contact Us

Thank you for visiting SVBSecurities.com. If you would like more information, please submit an inquiry below.

"*" indicates required fields

Name*